21 – 30 of 60
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs
- Contribution to journal › Article
- 2022
-
Mark
Experimental Model of Pulmonary Inflammation Induced by SARS-CoV-2 Spike Protein and Endotoxin
- Contribution to journal › Article
-
Mark
NFκB1 Dichotomously Regulates Pro-Inflammatory and Antiviral Responses in Asthma
- Contribution to journal › Article
-
Mark
Rapid in vitro and in vivo Evaluation of Antimicrobial Formulations Using Bioluminescent Pathogenic Bacteria
- Contribution to journal › Article
-
Mark
Editorial : Methods and applications in inflammation pharmacology
- Contribution to journal › Debate/Note/Editorial
-
Mark
SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade
- Contribution to journal › Article
-
Mark
Tartrate resistant acid phosphatase 5 (TRAP5) mediates immune cell recruitment in a murine model of pulmonary bacterial infection
- Contribution to journal › Article
-
Mark
Antibacterial and Anti-Inflammatory Effects of Apolipoprotein E
- Contribution to journal › Article
- 2021
-
Mark
The role of full-length apoE in clearance of Gram-negative bacteria and their endotoxins
- Contribution to journal › Article
-
Mark
Thrombin-derived C-terminal peptide reduces Candida-induced inflammation and infection in vitro and in vivo
- Contribution to journal › Article
